-+ 0.00%
-+ 0.00%
-+ 0.00%

Shuttle Pharmaceuticals Has Been Granted U.S Patent Number 12,357,650 Titled "Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorlylase Inhibitors In Combination With Radiation".

Benzinga·07/15/2025 19:59:03
Listen to the news

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12357650).pn